TerminatedNCT00827762

Behavioral Effects of Kuvan in Children With Mild Phenylketonuria

Studying Classic phenylketonuria

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Washington University School of Medicine
Principal Investigator
Desiree White, Ph.D.
Washington University School of Medicine
Intervention
Kuvan(drug)
Enrollment
2 enrolled
Eligibility
6-18 years · All sexes
Timeline
20092010

Study locations (4)

Collaborators

BioMarin Pharmaceutical · University of Missouri-Columbia · Northwestern University · Oregon Health and Science University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00827762 on ClinicalTrials.gov

Other trials for Classic phenylketonuria

Additional recruiting or active studies for the same condition.

See all trials for Classic phenylketonuria

← Back to all trials